Long-Term Outcome After Stroke in Belarus: The Grodno Stroke Study
Abstract
Background and Purpose—
Data concerning the long-term prognosis after stroke in low-income and middle-income countries are limited. We aimed to establish survival and dependency at 5 years after a first-ever-in-a-lifetime stroke in Grodno, Belarus.
Methods—
All residents of Grodno with a suspected acute stroke were registered prospectively and assessed over a period of 12 months in 2001. Patients were followed-up prospectively at 3 and 12 months, and then annually up to 5 years after the index event.
Results—
There were 671 cases of first-ever-in-a-lifetime stroke, and follow-up data after 5 years were available for 653 of these patients (97.3%); 18 people (2.7%) were lost to follow-up. One hundred ninety patients (29.1%) died during the first 28 days of stroke. The case fatality rate at 3 months was 32.2% (210/653), at 12 months it was 37.4% (244/653), and at 5 years it was 58.8% (384/653). Of the 269 survivors at 5 years, 130 (48.3%) were independent (modified Rankin score, 0–2), and 139 (51.7%) were disabled (modified Rankin score, ≥3). At 5 years, the cumulative risk of death or disability after first-ever-in-a-lifetime stroke was 80.1% (523/653).
Conclusions—
Stroke in Belarus is associated with a very high risk of death or dependency at 5 years.
Introduction
Countries of low and middle incomes have the largest burden of stroke, accounting for >85% of stroke mortality worldwide,1 but few reliable data on long-term outcome are available in most of these regions. In this study, we aimed to follow-up for 5 years stroke patients who participated in the first year of the Grodno Stroke Study (GROSS).2
Subjects and Methods
The GROSS registered all strokes among 311 134 residents of the city of Grodno, Belarus, during a 3-year period from 2001 to 2003.2 A cohort of patients with a nonfatal first-ever-in-a-lifetime stroke (FELS) registered in 2001 was followed-up prospectively at 3 and 12 months, and then annually for up to 5 years after the index event for survival, recurrent strokes, and disability (Supplemental Methods, http://stroke.ahajournals.org).
Results
Six hundred seventy-one cases of FELS were registered in the GROSS during 2001. After 5 years, 18 people (2.7%) were lost, and complete follow-up data were available for 653 patients (97.3%). The mean (±SD) age of these patients at baseline was 65.4±11.4 years. The 5-year cumulative risk of death (Figure and Supplemental Table I) was 58.8% (95% confidence interval [CI], 53.3%–64.7%). The risk of death was greatest during the first year after stroke (37.4%; 95% CI, 33.0%–42.3%) and, particularly, during the first 28 days after stroke (29.1%; 95% CI, 25.2%–33.6%). Stratification by age showed (Supplemental Figure I) that older patients had a worse prognosis (χ2 trend, 65.3; P<0.000001). Over the whole follow-up period there were 104 recurrent strokes (22.5%) among the 463 survivors of 28 days, with the case-fatality of 43.3% (45/104).
Data on the functional outcome 5 years after FELS by modified Rankin score (mRS) are presented in the Table. The proportion of disabled patients (mRS, ≥3) among all the survivors increased stepwise with age from 30.8% in the age group younger than 45 years to 90.5% in the age group of those aged 75 to 84 years. Of the survivors, <50% of the patients were functionally independent (mRS, <3). The mean (±SD) value of mRS for all 5-year survivors (n=269) was 2.52±1.28. The cumulative risk of death or disability after a first-ever stroke at 5 years was 80.1% (523/653; 95% CI, 73.3%–87.3%).
Age, y | No. Disabled/No. Survived | Rate of Disability, % |
---|---|---|
Younger than 45 | 4/13 | 30.8 |
45–54 | 21/55 | 38.2 |
55–64 | 47/99 | 47.5 |
65–74 | 47/80 | 58.8 |
75–84 | 19/21 | 90.5 |
85 or older | 1/1 | 100 |
All ages | 139/269 | 51.7 |
Discussion
We conducted a community-based study of 5-year outcome after FELS in a large defined urban population of the east European non-European Union countries. Our study provides prognostic data from a large, unselected, community-based inception cohort of patients with FELS diagnosed prospectively after a standardized neurological assessment and using standardized diagnostic criteria. The outcome events were carefully defined, and only 2.7% of patients were lost to follow-up.
Our study has several limitations. Because of the low rate of imaging/autopsy at baseline (37.1%; 242/653), we could not perform stratification of outcomes by the type of stroke. Data on clinical features of FELS were not registered, and functional outcome estimates were limited to poststroke mRS value.
The cumulative risk of death at 5 years after FELS of 59% (95% CI, 53.3%–64.7%) in the Belarusian urban population is significantly higher than in Framingham, Massachusetts, United States (45%; 95% CI, 38.8%–52.2%),3 Auckland, New Zealand (49%; 95% CI, 46.2%–52.9%),4 Martinique, French West Indies (50%; 95% CI, 44.2%–55.4%),5 Oxford, United Kingdom (50%; 95% CI, 45.0%–55.6%),6 and 6 communities in Japan (52%; 95% CI, 44.5%–61.0%),7 but similar to those in Rochester, Minnesota, United States (56%; 95% CI, 48.3%–66.1%),8 and Perth, Australia (58%; 95% CI, 50.3%–66.7%).9 Mean age at baseline of patients in Grodno (65.4 years) was the lowest compares to that of other studies (70.1–73.0 years4,8,9). Five years after the FELS, 48.3% (130/269) of the survivors in Grodno were functionally independent (mRS, <3); it is significantly lower than in Rochester (65.2%; 75/115),8 Martinique (66.4%; 174/262),5 and Auckland (68.8%; 287/418).4 At the same time, the mean mRS score among 5-year survivors in the GROSS of 2.52±1.28 is 1.5-times higher compared to the corresponding index in the ASTRO (1.7±1.5; P<0.00001).4 In our opinion, these findings reflect greater severity of stroke in the Belarusian urban population and are in agreement with high incidence, case fatality, and prevalence of vascular risk factors in Grodno.2
Our findings of 59% cumulative risk of death at 5 years after FELS for the younger mean age at baseline of the initial cohort compared to other studies and the <50% rate of functionally independent survivors demonstrate a clear need for active and prolonged secondary prevention. Our data on the long-term stroke outcomes are important for public health prevention programs as well as for evidence-based rehabilitation service planning and health resource allocation.
Supplemental Material
File (625400_supp.pdf)
- Download
- 136.11 KB
Sources of Funding
This study was supported by grants from Grodno Regional Healthcare Administration and Grodno State Medical University.
References
1.
Feigin VL. Stroke in developing countries: can the epidemic be stopped and outcomes improved? Lancet Neurol. 2007;6:94–97.
2.
Kulesh SD, Filina NA, Frantava NM, Zhytko NL, Kastsinevich TM, Kliatskova LA, et al. Incidence and case-fatality of stroke on the east border of the European union: the Grodno Stroke Study. Stroke. 2010;41:2726–2730.
3.
Sacco RL, Wolf PA, Kannel WB, McNamara PM. Survival and recurrence following stroke: the Framingham study. Stroke. 1982;13:290–295.
4.
Feigin VL, Barker-Collo S, Parag V, Senior H, Lawes CM, Ratnasabapathy Y, et al. Auckland Stroke Outcomes Study. Part 1: Gender, stroke types, ethnicity, and functional outcomes 5 years poststroke. Neurology. 2010;75:1597–1607.
5.
Chausson N, Olindo S, Cabre P, Saint-Vil M, Smadja D. Five-year outcome of a stroke cohort in Martinique, French West Indies: Etude Realisee en Martinique et Centree sur l'Incidence des Accidents Vasculaires Cerebraux, Part 2. Stroke. 2010;41:594–599.
6.
Dennis MS, Burn JP, Sandercock PA, Bamford JM, Wade DT, Warlow CP. Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project. Stroke. 1993;24:796–800.
7.
Ikebe T, Ozawa H, Lida M, Shimamoto T, Handa K, Komachi Y. Long-term prognosis after stroke: a community-based study in Japan. J Epidemiol. 2001;11:8–15.
8.
Dombovy M, Basford J, Whisnant J, Bergstrahl E. Disability and use of rehabilitation services following stroke in Rochester, Minnesota, 1975–1979 Stroke. 1987;18:830–836.
9.
Hankey GJ, Jamrozik K, Broadhurst RJ, Forbes S, Burvill PW, Anderson CS, et al. Five-year survival after first-ever stroke and related prognostic factors in the Perth Community Stroke Study. Stroke. 2000;31:2080–2086.
Information & Authors
Information
Published In
Copyright
© 2011 American Heart Association, Inc.
Versions
You are viewing the most recent version of this article.
History
Received: 5 May 2011
Accepted: 10 May 2011
Published online: 11 August 2011
Published in print: November 2011
Keywords
Subjects
Authors
Disclosures
None.
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
- Functional outcomes among stroke patients in Alagoas, Brazil: observational study, Sao Paulo Medical Journal, 139, 2, (156-162), (2021).https://doi.org/10.1590/1516-3180.2020.0304.r2.10122020
- Long-term survival after stroke in Lithuania: Data from Kaunas population-based stroke registry, PLOS ONE, 14, 7, (e0219392), (2019).https://doi.org/10.1371/journal.pone.0219392
- Employment sustainability after return to work among Japanese stroke survivors, International Archives of Occupational and Environmental Health, 91, 6, (717-724), (2018).https://doi.org/10.1007/s00420-018-1319-2
- How Many Patients Become Functionally Dependent after a Stroke? A 3-Year Population-Based Study in Joinville, Brazil, PLOS ONE, 12, 1, (e0170204), (2017).https://doi.org/10.1371/journal.pone.0170204
- Three-year survival and recurrence after first-ever stroke: the Joinville stroke registry, BMC Neurology, 15, 1, (2015).https://doi.org/10.1186/s12883-015-0317-1
- Time Trends in Incidence of Pathological and Etiological Stroke Subtypes during 16 Years: The Erlangen Stroke Project, Neuroepidemiology, 44, 1, (24-29), (2015).https://doi.org/10.1159/000371353
- Improving the Efficacy of Ipsilesional Brain-Computer Interface Training in Neurorehabilitation of Chronic Stroke, Brain-Computer Interface Research, (75-84), (2014).https://doi.org/10.1007/978-3-642-54707-2_8
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
Purchase this article to access the full text.
eLetters(0)
eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.
Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.